These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23391749)

  • 21. Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.
    Lee YY; Choi CH; Do IG; Song SY; Lee W; Park HS; Song TJ; Kim MK; Kim TJ; Lee JW; Bae DS; Kim BG
    Gynecol Oncol; 2011 Aug; 122(2):361-5. PubMed ID: 21570711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.
    Sun S; Cai J; Yang Q; Zhao S; Wang Z
    Oncotarget; 2017 Feb; 8(9):16036-16051. PubMed ID: 27980217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.
    Bompiani KM; Tsai CY; Achatz FP; Liebig JK; Howell SB
    Metallomics; 2016 Sep; 8(9):951-62. PubMed ID: 27157188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila.
    Hua H; Günther V; Georgiev O; Schaffner W
    Biometals; 2011 Jun; 24(3):445-53. PubMed ID: 21465178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Structure-functional organization of eukaryotic high-affinity copper importer CTR1 determines its ability to transport copper, silver and cisplatin].
    Skvortsov AN; Zatulovskiĭ EA; Puchkova LV
    Mol Biol (Mosk); 2012; 46(2):335-47. PubMed ID: 22670529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging roles of metal solute carriers in cancer mechanisms and treatment.
    Jong NN; McKeage MJ
    Biopharm Drug Dispos; 2014 Nov; 35(8):450-62. PubMed ID: 24889085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
    Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
    Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The copper transporter CTR1 provides an essential function in mammalian embryonic development.
    Kuo YM; Zhou B; Cosco D; Gitschier J
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6836-41. PubMed ID: 11391004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
    Du X; Wang X; Li H; Sun H
    Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
    Ip V; Liu JJ; McKeage MJ
    Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):371-8. PubMed ID: 23556474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobilization of intracellular copper stores by the ctr2 vacuolar copper transporter.
    Rees EM; Lee J; Thiele DJ
    J Biol Chem; 2004 Dec; 279(52):54221-9. PubMed ID: 15494390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain.
    Öhrvik H; Logeman B; Turk B; Reinheckel T; Thiele DJ
    J Biol Chem; 2016 Jul; 291(27):13905-13916. PubMed ID: 27143361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relations between CTR1 gene activity and copper status in different rat organs].
    Samsonov SA; Platonova NA; Skvortsov AN; Tsymbalenko NV; Vasin AV; Puchkova LV
    Mol Biol (Mosk); 2006; 40(2):239-51. PubMed ID: 16637264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells.
    Akerfeldt MC; Tran CM; Shen C; Hambley TW; New EJ
    J Biol Inorg Chem; 2017 Jul; 22(5):765-774. PubMed ID: 28516214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences.
    Ilyechova EY; Bonaldi E; Orlov IA; Skomorokhova EA; Puchkova LV; Broggini M
    Cells; 2019 Apr; 8(4):. PubMed ID: 30959888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saving ears and kidneys from cisplatin.
    Wensing KU; Ciarimboli G
    Anticancer Res; 2013 Oct; 33(10):4183-8. PubMed ID: 24122981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human copper transporter Ctr1 is functional in Drosophila, revealing a high degree of conservation between mammals and insects.
    Hua H; Georgiev O; Schaffner W; Steiger D
    J Biol Inorg Chem; 2010 Jan; 15(1):107-13. PubMed ID: 19856191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transporters, chaperones, and P-type ATPases controlling grapevine copper homeostasis.
    Leng X; Mu Q; Wang X; Li X; Zhu X; Shangguan L; Fang J
    Funct Integr Genomics; 2015 Nov; 15(6):673-84. PubMed ID: 26054906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.